Learning objectives
After watching this webinar, participants will:
Needs assessment and expected educational outcome
To be aware of the latest evidence about antiplatelet treatment for patients with cardiovascular diseases, including use of SAPT, DAPT, and dual antithrombotic therapy.
This programme is supported by Bayer AG in the form of an unrestricted financial support. The scientific programme has not been influenced in any way by its sponsor.
Main topic
Related topic
Session information
This webinar is designed for Clinical and non-clinical scientists and general cardiologists.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
Technical settings
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).